Efficacy of Humira(Adalimumab) in patients with moderate to severe ulcerative colitis (KyuSyu IBD project)

Trial Profile

Efficacy of Humira(Adalimumab) in patients with moderate to severe ulcerative colitis (KyuSyu IBD project)

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 03 May 2017

At a glance

  • Drugs Adalimumab (Primary)
  • Indications Ulcerative colitis
  • Focus Therapeutic Use
  • Acronyms HAWKS study
  • Most Recent Events

    • 02 Nov 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top